Dr. Mahiuddin Ahmed is a biochemist, yogi and biotechnology executive. He is currently the President and Chief Scientific Officer of VITRUVIAE LLC, a biotechnology company focused on developing vaccines and antibody therapeutics for Infectious Diseases, Neuroimmune Diseases and Cancer.
Dr. Ahmed was formerly a faculty member in the Department of Pediatrics at Memorial Sloan Kettering Cancer Center in New York City and the SVP and Chief Scientific Officer of Y-mAbs Therapeutics (NASDAQ: YMAB), where he co-invented several therapies for the treatment of pediatric cancers. Dr. Ahmed has been a Naam Yoga teacher since 2006, a Harmonyum practitioner and an active researcher in the fields of meditation and yoga practices. He currently serves on the board of directors for the Institute for Meditation Sciences and Naam Yoga New York.